Abstract:MOTIVATION: Fine mapping is a widely used approach for identifying the causal variant(s) at disease-associated loci. Standard methods (e.g. multiple regression) require individual level genotypes. Recent fine mapping methods using summary-level data require the pairwise correlation coefficients ([Formula: see text]) of the variants. However, haplotypes rather than pairwise [Formula: see text], are the true biological representation of linkage disequilibrium (LD) among multiple loci. In this article, we present an empirical iterative method, HAPlotype Regional Association analysis Program (HAPRAP), that enables fine mapping using summary statistics and haplotype information from an individual-level reference panel.RESULTS: Simulations with individual-level genotypes show that the results of HAPRAP and multiple regression are highly consistent. In simulation with summary-level data, we demonstrate that HAPRAP is less sensitive to poor LD estimates. In a parametric simulation using Genetic Investigation of ANthropometric Traits height data, HAPRAP performs well with a small training sample size (N < 2000) while other methods become suboptimal. Moreover, HAPRAP's performance is not affected substantially by single nucleotide polymorphisms (SNPs) with low minor allele frequencies. We applied the method to existing quantitative trait and binary outcome meta-analyses (human height, QTc interval and gallbladder disease); all previous reported association signals were replicated and two additional variants were independently associated with human height. Due to the growing availability of summary level data, the value of HAPRAP is likely to increase markedly for future analyses (e.g. functional prediction and identification of instruments for Mendelian randomization).AVAILABILITY AND IMPLEMENTATION: The HAPRAP package and documentation are available at http://apps.biocompute.org.uk/haprap/ CONTACT: : jie.zheng@bristol.ac.uk or tom.gaunt@bristol.ac.ukSupplementary information: Supplementary data are available at Bioinformatics online.

CARMA is a new Bayesian model for fine-mapping in genome-wide association meta-analyses

Funmap: integrating high-dimensional functional annotations to improve fine-mapping

Genome-wide fine-mapping improves identification of causal variants

Beyond guilty by association at scale: searching for causal variants on the basis of genome-wide summary statistics

SEMI-PARAMETRIC COVARIATE-MODULATED LOCAL FALSE DISCOVERY RATE FOR GENOME-WIDE ASSOCIATION STUDIES

Finemap-MiXeR: A variational Bayesian approach for genetic finemapping

BEATRICE: Bayesian Fine-mapping from Summary Data using Deep Variational Inference

Probabilistic Fine-mapping of Putative Causal Genes

MESuSiE enables scalable and powerful multi-ancestry fine-mapping of causal variants in genome-wide association studies

Novel Association Strategy with Copy Number Variation for Identifying New Risk Loci of Human Diseases

Searching Genome-Wide Multi-Locus Associations for Multiple Diseases Based on Bayesian Inference.

A Bayesian Framework for Generalized Linear Mixed Modeling Identifies New Candidate Loci for Late-Onset Alzheimer's Disease

A Bayesian fine-mapping model using a continuous global-local shrinkage prior with applications in prostate cancer analysis

DAM: A Bayesian Method for Detecting Genome-wide Associations on Multiple Diseases.

Methods for multiancestry genome‐wide association study meta‐analysis

Model-based clustering for identifying disease-associated SNPs in case-control genome-wide association studies

Bayesian group Lasso for nonparametric varying-coefficient models with application to functional genome-wide association studies

Fine-mapping across diverse ancestries drives the discovery of putative causal variants underlying human complex traits and diseases

HAPRAP: a haplotype-based iterative method for statistical fine mapping using GWAS summary statistics

graph-GPA 2.0: A Graphical Model for Multi-disease Analysis of GWAS Results with Integration of Functional Annotation Data

Computational Assessment of the Regulation-Modulating Potential for Noncoding Variants